Patients with ST-segment elevation of myocardial infarction miss out on early reperfusion: when to undergo delayed

Wen Zheng1,2, Cheuk-Man Yu3, Jing Liu1

  • 1Department of Epidemiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, No.2 Anzhen Road, Chaoyang District, Beijing, China.

Insights

Optimal timing for delayed percutaneous coronary intervention (PCI) after ST-segment elevation myocardial infarction (STEMI) is crucial. Performing PCI in the second week post-STEMI offers improved survival benefits and reduced adverse events for stable patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Many ST-segment elevation myocardial infarction (STEMI) patients miss early reperfusion therapy, even with primary percutaneous coronary intervention (PCI).
  • Optimal timing for delayed PCI in stable STEMI patients remains debated, impacting clinical outcomes.

Purpose of the Study:

  • To determine the optimal timing for delayed PCI in stable STEMI patients who did not receive early reperfusion.
  • To evaluate the association between delayed PCI timing and major adverse cardiovascular events (MACEs).

Main Methods:

  • Retrospective analysis of 5,417 STEMI patients undergoing delayed PCI (2-28 days post-STEMI) between 2007-2010.
  • Exclusion of hemodynamically unstable patients; primary outcome was MACEs over 1-year follow-up.
  • Patients categorized into Early (2-7 days), Medium (8-14 days), and Late (15-28 days) PCI groups.

Main Results:

  • The Medium PCI group (8-14 days) showed a significantly lower incidence of MACEs compared to the Late group (15-28 days).
  • The Medium group experienced fewer recurrent myocardial infarctions plus cardiac deaths and less repeat revascularization compared to the Early group (2-7 days).
  • Analysis revealed the lowest MACE incidence occurred at approximately 14 days post-STEMI.

Conclusions:

  • Delayed PCI timing in real-world practice varies significantly.
  • Undergoing PCI during the second week after STEMI provides superior survival benefits and fewer adverse events for stable patients without early reperfusion.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315